91 related articles for article (PubMed ID: 22157753)
1. Regulation of sodium iodide symporter gene expression by Rac1/p38β mitogen-activated protein kinase signaling pathway in MCF-7 breast cancer cells.
Kogai T; Liu YY; Mody K; Shamsian DV; Brent GA
J Biol Chem; 2012 Jan; 287(5):3292-300. PubMed ID: 22157753
[TBL] [Abstract][Full Text] [Related]
2. CMTM 6 promotes the development of thyroid cancer by inhibiting NIS activity through activating the MAPK signaling pathway.
Chen X; Shen H; Liu H; Tan L; Zhang N
Funct Integr Genomics; 2024 Jan; 24(1):10. PubMed ID: 38221563
[TBL] [Abstract][Full Text] [Related]
3. Alantolactone induces apoptosis and suppresses migration in MCF‑7 human breast cancer cells via the p38 MAPK, NF‑κB and Nrf2 signaling pathways.
Liu J; Liu M; Wang S; He Y; Huo Y; Yang Z; Cao X
Int J Mol Med; 2018 Oct; 42(4):1847-1856. PubMed ID: 30015828
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of survivin expression and apoptosis by vitamin D3 compounds in two isogenic MCF-7 breast cancer cell sublines.
Li F; Ling X; Huang H; Brattain L; Apontes P; Wu J; Binderup L; Brattain MG
Oncogene; 2005 Feb; 24(8):1385-95. PubMed ID: 15608672
[TBL] [Abstract][Full Text] [Related]
5. Mechanical Stress Signaling in Pancreatic Cancer Cells Triggers p38 MAPK- and JNK-Dependent Cytoskeleton Remodeling and Promotes Cell Migration via Rac1/cdc42/Myosin II.
Kalli M; Li R; Mills GB; Stylianopoulos T; Zervantonakis IK
Mol Cancer Res; 2022 Mar; 20(3):485-497. PubMed ID: 34782370
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 promotes the dedifferentiation of papillary thyroid cancer cells.
Zhang GQ; Xi C; Shen CT; Song HJ; Luo QY; Qiu ZL
Endocr Relat Cancer; 2023 Sep; 30(9):. PubMed ID: 37260320
[TBL] [Abstract][Full Text] [Related]
7. Proto-oncogene PBF/PTTG1IP regulates thyroid cell growth and represses radioiodide treatment.
Read ML; Lewy GD; Fong JC; Sharma N; Seed RI; Smith VE; Gentilin E; Warfield A; Eggo MC; Knauf JA; Leadbeater WE; Watkinson JC; Franklyn JA; Boelaert K; McCabe CJ
Cancer Res; 2011 Oct; 71(19):6153-64. PubMed ID: 21844185
[TBL] [Abstract][Full Text] [Related]
8. Role of sodium/iodide symporter overexpression in inhibiting thyroid cancer cell invasion and stem cell maintenance by inhibiting the β-catenin/LEF-1 pathway.
Luo NF; Li JL; Lv J; Chen FK; Li YN; Tang M; Liu PJ
Heliyon; 2024 Mar; 10(6):e27840. PubMed ID: 38545139
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-conjugating enzyme Ubc13 controls breast cancer metastasis through a TAK1-p38 MAP kinase cascade.
Wu X; Zhang W; Font-Burgada J; Palmer T; Hamil AS; Biswas SK; Poidinger M; Borcherding N; Xie Q; Ellies LG; Lytle NK; Wu LW; Fox RG; Yang J; Dowdy SF; Reya T; Karin M
Proc Natl Acad Sci U S A; 2014 Sep; 111(38):13870-5. PubMed ID: 25189770
[TBL] [Abstract][Full Text] [Related]
10. Translational control of breast cancer plasticity.
Jewer M; Lee L; Leibovitch M; Zhang G; Liu J; Findlay SD; Vincent KM; Tandoc K; Dieters-Castator D; Quail DF; Dutta I; Coatham M; Xu Z; Puri A; Guan BJ; Hatzoglou M; Brumwell A; Uniacke J; Patsis C; Koromilas A; Schueler J; Siegers GM; Topisirovic I; Postovit LM
Nat Commun; 2020 May; 11(1):2498. PubMed ID: 32427827
[TBL] [Abstract][Full Text] [Related]
11. Isoform-specific optical activation of kinase function reveals p38-ERK signaling crosstalk.
Zhou W; Ryan A; Janosko CP; Shoger KE; Haugh JM; Gottschalk RA; Deiters A
RSC Chem Biol; 2023 Oct; 4(10):765-773. PubMed ID: 37799579
[TBL] [Abstract][Full Text] [Related]
12. Rac1 activation in oral squamous cell carcinoma as a predictive factor associated with lymph node metastasis.
Yamazaki M; Sekikawa S; Suzuki T; Ogane S; Hashimoto K; Sasaki A; Nomura T
Int J Clin Oncol; 2023 Sep; 28(9):1129-1138. PubMed ID: 37418142
[TBL] [Abstract][Full Text] [Related]
13. Analysis of NIS Plasma Membrane Interactors Discloses Key Regulation by a SRC/RAC1/PAK1/PIP5K/EZRIN Pathway with Potential Implications for Radioiodine Re-Sensitization Therapy in Thyroid Cancer.
Faria M; Domingues R; Bugalho MJ; Silva AL; Matos P
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771624
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: Impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS.
Oh JM; Ahn BC
Theranostics; 2021; 11(13):6251-6277. PubMed ID: 33995657
[TBL] [Abstract][Full Text] [Related]
15. Epidermal Growth Factor and Adenosine Triphosphate Induce Natrium Iodide Symporter Expression in Breast Cancer Cell Lines.
Elliyanti A; Putra AE; Sribudiani Y; Noormartany N; Masjhur JS; Achmad TH; Dachriyanus D
Open Access Maced J Med Sci; 2019 Jul; 7(13):2088-2092. PubMed ID: 31456831
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and Clinicopathological Value of Rac1 in Cancer Survival: Evidence from a Meta-Analysis.
Lou S; Wang P; Yang J; Ma J; Liu C; Zhou M
J Cancer; 2018; 9(14):2571-2579. PubMed ID: 30026856
[No Abstract] [Full Text] [Related]
17. GLIS3 is indispensable for TSH/TSHR-dependent thyroid hormone biosynthesis and follicular cell proliferation.
Kang HS; Kumar D; Liao G; Lichti-Kaiser K; Gerrish K; Liao XH; Refetoff S; Jothi R; Jetten AM
J Clin Invest; 2017 Dec; 127(12):4326-4337. PubMed ID: 29083325
[TBL] [Abstract][Full Text] [Related]
18. The correlation between breast cancer and urinary iodine excretion levels.
Malya FU; Kadioglu H; Hasbahceci M; Dolay K; Guzel M; Ersoy YE
J Int Med Res; 2018 Feb; 46(2):687-692. PubMed ID: 28856936
[TBL] [Abstract][Full Text] [Related]
19. Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer.
Micali S; Bulotta S; Puppin C; Territo A; Navarra M; Bianchi G; Damante G; Filetti S; Russo D
BMC Cancer; 2014 Apr; 14():303. PubMed ID: 24884806
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
